Cargando…
TNAP and P2X7R: New Plasma Biomarkers for Alzheimer’s Disease
Over the last few years, intense research efforts have been made to anticipate or improve the diagnosis of Alzheimer’s disease by detecting blood biomarkers. However, the most promising blood biomarkers identified to date have some limitations, most of them related to the techniques required for the...
Autores principales: | Aivar, Paloma, Bianchi, Carolina, Di Lauro, Caterina, Soria-Tobar, Lucia, Alvarez-Castelao, Beatriz, Calero, Miguel, Medina, Miguel, Diaz-Hernandez, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342008/ https://www.ncbi.nlm.nih.gov/pubmed/37446074 http://dx.doi.org/10.3390/ijms241310897 |
Ejemplares similares
-
P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease
por: Bianchi, Carolina, et al.
Publicado: (2023) -
The Role of P2X7 Receptor in Alzheimer’s Disease
por: Francistiová, Linda, et al.
Publicado: (2020) -
Haploinsufficient TNAP Mice Display Decreased Extracellular ATP Levels and Expression of Pannexin-1 Channels
por: Sebastián-Serrano, Álvaro, et al.
Publicado: (2018) -
Editorial: Protein Degradation, Aggregation, Membrane Trafficking and Exosomes in Neuronal Health and Disease
por: Campbell, Douglas S., et al.
Publicado: (2022) -
TNAP: A New Multitask Enzyme in Energy Metabolism
por: Briolay, Anne, et al.
Publicado: (2021)